Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

67 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Understanding ART Adherence among Adolescent Girls and Young Women in Western Kenya: A Cross-Sectional Study of Barriers and Facilitators.
Altamirano J, Odero IA, Omollo M, Awuonda E, Ondeng'e K, Kang JL, Behl R, Ndivo R, Baiocchi M, Barsosio HC, Sarnquist CC. Altamirano J, et al. Among authors: behl r. Int J Environ Res Public Health. 2023 Oct 14;20(20):6922. doi: 10.3390/ijerph20206922. Int J Environ Res Public Health. 2023. PMID: 37887660 Free PMC article.
Meta-analysis of HNF1A-MODY3 variants among human population.
Behl R, Malhotra N, Joshi V, Poojary S, Middha S, Gupta S, Olaonipekun AB, Okoye I, Wagh B, Biswas D, Aginah C, Saini B, Nwanya C, Ugwu S, Anthony MM, Fang XS, Foluso O, Ibrahim AT. Behl R, et al. J Diabetes Metab Disord. 2022 Feb 2;21(1):1037-1046. doi: 10.1007/s40200-022-00975-8. eCollection 2022 Jun. J Diabetes Metab Disord. 2022. PMID: 35673428 Free PMC article. Review.
Addition of elotuzumab to lenalidomide and dexamethasone for patients with newly diagnosed, transplantation ineligible multiple myeloma (ELOQUENT-1): an open-label, multicentre, randomised, phase 3 trial.
Dimopoulos MA, Richardson PG, Bahlis NJ, Grosicki S, Cavo M, Beksaç M, Legieć W, Liberati AM, Goldschmidt H, Belch A, Magen H, Larocca A, Laubach JP, Petrucci MT, Reece D, White D, Mateos MV, Špička I, Lazaroiu M, Berdeja J, Kaufman JL, Jou YM, Ganetsky A, Popa McKiver M, Lonial S, Weisel K; ELOQUENT-1 investigators. Dimopoulos MA, et al. Lancet Haematol. 2022 Jun;9(6):e403-e414. doi: 10.1016/S2352-3026(22)00103-X. Epub 2022 May 9. Lancet Haematol. 2022. PMID: 35550060 Clinical Trial.
67 results